The Pharmacokinetics of 2% TD1414 Cream in Adults With Secondarily Infected Traumatic Lesions (SITL) or Impetigo.
Phase of Trial: Phase II
Latest Information Update: 27 Jul 2018
At a glance
- Drugs TD 1414 (Primary)
- Indications Bacterial infections; Impetigo; Wound infections
- Focus Pharmacokinetics
- Sponsors LEO Pharma
- 14 Aug 2009 Actual patient number (20) added as reported by ClinicalTrials.gov.
- 14 Aug 2009 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 14 Aug 2009 Actual initiation date (Dec 2008) added as reported by ClinicalTrials.gov.